Showing 1 - 10 of 147
Internationalisation is a useful strategy to gain firm specific advantages during periods of technological discontinuity. The pharmaceutical industry offers us two such episodes as examples: when the antibiotics revolution was beginning and when the possibilities of genetic routes to new drug...
Persistent link: https://www.econbiz.de/10010712292
Translating R&D and inventive efforts into a market product is characterized by significant financial skills, and the ability to overcome technical and instititonal barriers. Research into and translation of new technologies such as biotechnology products to the market requires even greater...
Persistent link: https://www.econbiz.de/10010712041
The life sciences sector (and biotechnology in particular) has emerged as a prospective area, and attracted a lot of attention recently. Multinational companies in the life sciences seek to explore new markets, and, on the other side, governments strive to develop the life sciences sector...
Persistent link: https://www.econbiz.de/10010712051
This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade...
Persistent link: https://www.econbiz.de/10010712160
In pursuit of innovation, developing countries play an increasingly relevant role for multinational pharmaceutical firms. Driven partly by cost considerations but also by some host country-specific scientific and technological factors, global drug companies increasingly relocate part of their...
Persistent link: https://www.econbiz.de/10010712249
Along with the rapid growth of nanoscience research and the wide application of nanotechnology into various industrial fields, the innovation patterns and co-evolutionary natures of multiple nano industrial sectors has drawn much attention from scholars. Based on a continuously updated...
Persistent link: https://www.econbiz.de/10010712306
This paper focuses on the occurrence of high-growth firms in relation to human capital and innovation. High-growth firms are rather exceptional and temporary phenomena and occur in the upper tail of the conditional firm growth distribution. Using quantile regression we study how human capital...
Persistent link: https://www.econbiz.de/10011254928
This introduction to a special issue of EINT surveys a collection of ten papers that study various aspects of innovation and knowledge management and their impact on performance at the firm level for a number of countries. These studies have been conducted using data drawn from innovation...
Persistent link: https://www.econbiz.de/10010856374
In recent years, a number of firms from Asia and Latin America have been internationalizing their businesses to access new markets and to acquire new technology. This follows similar attempts only a few years earlier by leading firms from countries such as Korea and Taiwan. Much research has...
Persistent link: https://www.econbiz.de/10010712042
Using a large dataset of over 100,000 Chinese firms created between 2000 and 2006, we explore whether there is a link between innovation effort (R&D) or innovation output (the share of innovative sales) and the firm's duration of survival. We estimate a complementary log-log model with...
Persistent link: https://www.econbiz.de/10010712215